APA

Wu Y., Lu S., Cheng Y., Zhou C., Wang J., Mok T., Zhang L., Tu H., Wu L., Feng J., Zhang Y., Luft A. V., Zhou J., Ma Z., Lu Y., Hu C., Shi Y., Baudelet C., Cai J. & Chang J. (20200630). Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Wu Yi-Long, Lu Shun, Cheng Ying, Zhou Caicun, Wang Jie, Mok Tony, Zhang Li, Tu Hai-Yan, Wu Lin, Feng Jifeng, Zhang Yiping, Luft Alexander Valerievich, Zhou Jianying, Ma Zhiyong, Lu You, Hu Chengping, Shi Yuankai, Baudelet Christine, Cai Junliang and Chang Jianhua. 20200630. Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Wu Y., Lu S., Cheng Y., Zhou C., Wang J., Mok T., Zhang L., Tu H., Wu L., Feng J., Zhang Y., Luft A. V., Zhou J., Ma Z., Lu Y., Hu C., Shi Y., Baudelet C., Cai J. and Chang J. (20200630). Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Wu Yi-Long, Lu Shun, Cheng Ying, Zhou Caicun, Wang Jie, Mok Tony, Zhang Li, Tu Hai-Yan, Wu Lin, Feng Jifeng, Zhang Yiping, Luft Alexander Valerievich, Zhou Jianying, Ma Zhiyong, Lu You, Hu Chengping, Shi Yuankai, Baudelet Christine, Cai Junliang and Chang Jianhua. Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial. : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20200630.